Next Article in Journal / Special Issue
3-Amino-4-(diphenylamino)-1H-2-benzopyran-1-one
Previous Article in Journal
2,6-Bis(phenylamino)-4-(iminophenyl)benzoquinone
Previous Article in Special Issue
Synthesis and Evaluation of Self-Assembling Properties of 3-(3,5-Difluoro-3,5-bis((alkoxy)carbonyl)-2,6-dioxoheptan-4-yl)-1-methylpyridin-1-ium Iodides
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid

by
Ricaurte Rodríguez
1,*,
Felipe Quiroga-Suavita
1 and
Mónica Yadira Dotor Robayo
2
1
Investigation Group in Heterocyclic Chemistry, Chemistry Department, Universidad Nacional de Colombia-Sede Bogotá, Carrera 30, Calle 45-03, Bogotá 111321, Colombia
2
Residuality and Environmental Destination of Pesticides in Agricultural Systems, Agronomy Department, Universidad Nacional de Colombia-Sede Bogotá, Carrera 30, Calle 45-03, Bogotá 111321, Colombia
*
Author to whom correspondence should be addressed.
Molbank 2022, 2022(3), M1407; https://doi.org/10.3390/M1407
Submission received: 3 June 2022 / Revised: 4 July 2022 / Accepted: 8 July 2022 / Published: 12 July 2022
(This article belongs to the Collection Heterocycle Reactions)

Abstract

:
With the aim of obtaining derivatives belonging to 2′,3′-diphenyl-3H-spiro[[2]benzofuran-1,4′-imidazole]-3,5′(3′H)-dione nucleus, we synthesized 4-[(3-amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic acid (a 3,4-diaminoisocoumarine derivative), a known precursor of 4-[(1-carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic acid (a phthalide–carboxamide-bearing system) by a novel methodology that we report here. The reaction conditions were optimized to afford the latter in 62% yield.

Graphical Abstract

1. Introduction

Isocoumarins (1H-isochromen-1-ones or 1H-2-benzopyran-1-one) are notable organic compounds due to their key role in pharmaceutical research and a vast range of pharmacological activities [1,2,3]. These molecules have been obtained from various sources, including natural organisms such as fungi, lichens, marine sponges, and higher plants as protagonists [3,4,5,6,7]. Their extensive application areas have attracted the interest of organic and medicinal chemists, developing, and designing diverse synthetic methodologies to form it, not only from traditional, but also from metal-catalyzed pathways [8,9,10].
Isobenzofuranones (Isobenzofuran-1(3H)-ones), commonly named as phthalides, are considered to be privileged structures in organic, biological, and medicinal chemistry. Specifically, those nuclei have exhibited a wide variety of biological activities, such as herbicidal 1 [11,12], antioxidant 2 [13,14], anti-rotavirus 3 [15], anti-inflammatory 4 [16], antibacterial 5 [17], antifungal 6 [18,19], as well as antileishmanial [20] activities (Figure 1), deriving from natural or synthetic products.
Different routes to obtain phthalides have been designed due to the growing interest in these important compounds, from the cyclization of ortho-functionalized benzoic acids, the reduction of phthalic anhydrides and phthalaldehydic acids to cyclocarbonyl, or the cyclocarboxylation of halogen-benzyl alcohols [21], situating isobenzofuranones as leading products in the discovery of new drugs. Furthermore, isobenzofuranones have been used as precursors in the synthesis of other relevant heterocyclic compounds [22,23,24], demonstrating the versatility and applicability of this important organic scaffold.

2. Results and Discussion

During our recent work, we have designed the synthesis of spiro-compounds 7 through a three-step methodology, where synthesized diaminoisocoumarins 10 and subsequently 11-type compounds are involved, as shown in Scheme 1. Herein, we report two of the obtained precursors derivatives (10a and 11a) which, according to the SciFindern database, are new molecules.
The first step of the procedure consisted of the methodology previously reported by Opatz and Ferenc [25], where 2-formylbenzoic acid (8), arylamines (anilines) and KCN undergo a Strecker-type reaction to afford 3-amino-4-(4-arylamino)-1H-isochromen-1-ones, also named as diaminoisocoumarins. In one of our ongoing investigations, we needed to introduce a para-carboxy group into the diaminoisocoumarin structure; therefore, we evaluated the reaction behavior using 4-aminobenzoic acid (9) as an arylamine-reagent and carried out the reaction under the same reported conditions, achieving the expected diaminoisocoumarin 10a in a remarkable 71% yield as a bright yellow solid. (Scheme 2).
Additionally, we found a novel, simple, and reasonable method to achieve previously reported amide–aniline-bearing phthalides (1-(arylamino)-3-oxo-1,3-dihydroisobenzofuran-1-carboxamides) from diaminoisocoumarin (3-amino-4-(4-arylamino)-1H-isochromen-1-ones) moieties, based on an oxidative ring contracting rearrangement. To the best of our knowledge, there is only one report which describe the synthesis of those specific molecules [26], where Opatz and Ferenc used 10b-type compounds as reagents to obtain the aforementioned isobenzofuranones. We attempted the same procedure, carrying out the reaction without an argon atmosphere, unfortunately with no successful results. Serendipitously, we noticed that when the initial reagent was dissolved in DMF at room temperature, a subsequent precipitate was observed after 1 week of constant stirring. Controlling the reaction mixture by TLC, we concluded that a new product was forming. Further isolation and purification resulted in a white solid with 52% yield. 1H, 13C, and APT NMR experiments were carried out to characterize and identify the molecular structure of the product, showing us the unexpected formation of the phthalide moiety 11b (Scheme 3).
Aiming to synthetize the product in better yields, we added glacial HOAc to the aforementioned conditions. Interestingly, we afforded no significant improvement, but achieved a noticeable reaction time reduction as well as a slightly higher yield. In addition, another attempt with HOAc and higher temperature were performed, reaching a lower yield of the product within the same reaction time; the specific parameters and results are presented in Table 1.
According to the observations reported by Opatz, when 3-amino-4-(4-tolylamino)-1H-isochromen-1-one was dissolved in DMSO at room temperature, the formation of a single product could be observed. Further NMR analysis elucidated the compound structure to be 3-oxo-1-(4-tolylamino)-1,3-dihydroisobenzofuran-1-carboxamide. A mechanistic pathway was proposed, where DMSO behaved as an oxygen source. However, this hypothesis is not applicable to our case, basically due to the reaction solvent being DMF. Herein, we propose another approach of how this reaction occurs (Scheme 4), suggesting the air to be the oxygen source for the ring contracting rearrangement. Subsequent protonation of II to produce III leads to the lactone ring opening intermediate IV. Finally, a nucleophilic attack from the carboxylic oxygen recyclizes the system, forming 11. Notably, clear elucidation of the reaction pathway based on mechanistic studies is still necessary.
Having established the optimum conditions for the procedure, we decided to test the same reaction with 10a. Satisfactorily, we synthesized compound 11a in a competent yield of 64% (Scheme 5).
Compound 11a was characterized with a set of spectroscopic techniques (NMR and IR) and by its melting point. In the IR spectrum at 3428 and 3305 cm−1, a couple of absorption bands characteristic of N–H bonds of the carboxamide and aryl amino moieties were observed. Strong bands at 1770, 1675, and 1606 cm−1 were assigned to the carboxylic, lactone, and amide carbonyl groups, respectively. At 1325 cm−1, a strong band was assigned to the =C–N bond of the aromatic amine. Finally, absorption bands corresponding to C–O and C–N bonds appeared at 1249 and 1169 cm−1, respectively. The HR-MS featured a peak at m/z = 313.08211, which is in accordance with the [M + H]+ ion.
The 1H-NMR spectrum of the purified product showed a complete set of signals corresponding to the proposed structure. Therefore, the first at 6.86 ppm was a doublet assigned to H-4 protons. Two signals resonating at 7.68 and 8.20 ppm corresponded to both amide protons. Two broad multiplets, centered at 7.78 and 7.92 ppm, were determined to be the two H-3 and the H-11 protons for the former, and H-10, H-12, the H-13 protons for the latter. A well-defined singlet at 8.12 ppm was attributed to the ArNH proton, whereas a broad singlet at 12.48 ppm was designated as the signal of the carboxylic proton.
Additionally, as expected, 14 signals were observed in the 13C-NMR spectrum. Furthermore, ATP experiments supported these findings exhibiting eight signals for quaternary carbons. Three of them corresponded to the carbonyl groups at 168.4 (C-9) (lactone group), 167.8 (C-7′) (carboxamide group), and 167.2 ppm (C-1) (carboxylic group). At 93.7 ppm, there was another quaternary signal, which was characteristic of the single aliphatic carbon of the molecule (C-7). The other signals were assigned to aromatic carbons. All these observations are supported by 1H- 1H-COSY, 1H-13C-HSQC, and 1H-13C-HMBC spectra (see the Supplementary Materials); thus, this is in strong agreement with the proposed structure for 11a. Moreover, assignations were compared with Opatz and Ferenc’s report [26] of 1-(4-Trifluoromethyl-phenylamino)-3-oxo-1,3-dihydroisobenzofuran1-carboxamide, finding clear correlation between the aforementioned author findings and those reported here.

3. Conclusions

We have developed a new synthetic methodology to afford the carboxamide-phthalide 11a through an oxidative contraction ring rearrangement from a novel 3,4-diaminoisocoumarin derivative 10a obtained from a previously described procedure. We surmise that the proposed reaction scheme and the established conditions could shed some light on understanding the behavior of this unusual reaction. Additionally, we consider that the final product, 11a, could, prove useful to achieve more complex heterocyclic systems, as is the case of the aforementioned 2′,3′-diphenyl-3H-spiro[[2]benzofuran-1,4′-imidazole]-3,5′(3′H)-dione nucleus (7).

4. Materials and Methods

4.1. General Information

The reagents and solvents used were obtained from commercial sources and were used without previous purification. The reaction progress was monitored by TLC with 0.2 mm precoated plates of silica gel 60 F254 (Merck). The melting points were measured using Stuart SMP3 melting point apparatus (Cole-Parmer, Staffordshire, UK), and were corrected. The IR spectrum was recorded on a Shimadzu IR Affinity (Shimadzu, Kyoto, Japan) with an ATR probe. The 1H, 13C-NMR, 1H- 1H-COSY, 1H-13C-HSQC, and 1H-13C-HMBC spectra were recorded on a BRUKER DPX 400 spectrophotometer (Bruker, Bruker BioSpin GmbH, Rheinstetten, Germany), operating at 400 and 100 MHz, respectively (1H, 13C), using DMSO-d6 as the solvent. Chemical shifts (δ) are given in ppm and coupling constants (J) are given in Hz. The following abbreviations are used for multiplicities: s, singlet; d, doublet; t, triplet; dd, doublet of doublets; and m, multiplet. High-resolution mass spectra (HRMS) were recorded using an Agilent Technologies Q-TOF 6520 spectrometer by electrospray ionization (ESI).

4.2. Preparation of 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid (10a)

4-aminobenzoic acid (1.03 g, 7.5 mmol), acetic acid (0.43 mL, 7.5 mmol) and potassium cyanide (0.39 g, 6 mmol) were added to a stirred solution of 2-formylbenzoic acid (0.75 g, 5 mmol) in methanol (12 mL). The reaction mixture was refluxed for 4 h (the reaction progress was controlled by TLC). Once cooled, the yellow precipitate was filtered and washed with methanol, yielding 10a as a bright yellow solid.
Yield: 1.05 g, 71%. M.p. 168 °C (dec). FT-IR (KBr disk) ῡ (cm−1): 3508, 3366, 3183, 1703, 1647, 1603, 1551, 1468, 1268, 1169, 770, 594.1H NMR (400 MHz, DMSO-d6) δ (ppm) 6.58 (d, J = 7.7 Hz, 2H, 4-H), 6.70 (s, 2H, NH2), 6.99 (d, J = 8.1 Hz, 1H, 14-H), 7.09 (ddd, J = 8.1 Hz, 7.1 Hz, 1.1 Hz, 1H, 12-H), 7.52–7.55 (m, 2H, 13-H, NH), 7.67 (d, J = 9.1 Hz, 2H, 3-H), 7.92 (dd, J = 8.0 Hz, 1.1 Hz, 1H, 11-H). 13C NMR (100 MHz, DMSO-d6) δ (ppm) 89.4 (C-7), 112.1 (C-4), 114.0 (C-10a), 119.0 (C-2), 119.4 (C-14), 122.3 (C-12), 129.4 (C-11), 131.2 (C-3), 135.1 (C-13), 141.3 (C-14a), 152.0 (C-5), 156.0 (C-8), 160.3 (C-10), 167.6 (C-1 (COOH)). HR-MS (ESI): m/z calculated for [M + H]+: 297.28532, found: 297.08630.

4.3. Preparation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid (11a)

An excess of acetic acid (1.2 mL) was added to a stirred solution of 10a (0.59 g, 2 mmol) in DMF (4.7 mL) at room temperature and in open air. Once TLC indicated the complete conversion of 10a (48 h), distilled water was added to precipitate the product. The crude solid was filtered and washed with dichloromethane until a clear white solid was obtained, yielding 11a.
Yield: 0.39 g, 62%. M.p. 246 °C (dec). FT-IR (KBr disk) ῡ (cm−1): 3428, 3305, 1770, 1675, 1606, 1525, 1427, 1325, 1249, 1169, 1098, 903, 776, 748, 609. 1H NMR (400 MHz, DMSO-d6) δ (ppm) 6.86 (d, J = 8.8 Hz, 2H, 4-H), 7.68 (s, 1H, CONHb), 7.76–7.80 (m, 3H, 3-H,11-H), 7.90–7.94 (m, 3H, 10,12,13-H), 8.12 (s, 1H, ArNH), 8.20 (s, 1H, CONHa), 12.48 (s, 1H, COOH). 13C NMR (100 MHz, DMSO-d6) δ (ppm) 93.7 (C-7), 114.8 (C-4), 121.2 (C-2), 123.7 (C-13), 125.2 (C-10), 125.8 (C-9a), 130.6 (C-3), 131.4 (C-11), 135.0 (C-12), 146.1 (C-5), 148.2 (C-13a), 167.2 (C-1(COOH)), 167.8 (C-7′(CONH2)), 168.4 (C-9). HR-MS (ESI): m/z calculated for [M + H]+: 313.28472, found: 313.08211.

Supplementary Materials

The following supporting information can be downloaded online: Figure S1. 1H-NMR spectrum for compound 10a, Figure S2. 13C-NMR spectrum for compound 10a, Figure S3. APT spectrum for compound 10a, Figure S4. 1H- 13C-HSQC spectrum of compound 10a, Figure S5. 1H- 13C-HMBC spectrum for compound 10a, Figure S6. FT-IR spectrum of compound 10a, Figure S7. HR-MS of compound 10a, Figure S8. 1H-NMR spectrum for compound 11a, Figure S9. 13C-NMR spectrum for compound 11a, Figure S10. APT spectrum for compound 11a, Figure S11. 1H- 1H-COSY spectrum of compound 11a, Figure S12. 1H- 13C-HSQC spectrum of compound 11a, Figure S13. 1H- 13C-HMBC spectrum of compound 11a, Figure S14. FT-IR spectrum of compound 11a, Figure S15. HR-MS spectrum of compound 11a.

Author Contributions

R.R., F.Q.-S. and M.Y.D.R. designed and performed the research. Additionally, they analyzed data and wrote the paper together. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. Part of the APC was sponsored by MDPI.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in this article.

Acknowledgments

The authors wish to thank the Universidad Nacional de Colombia-Sede Bogotá and Dirección de Investigación y Extensión, Sede Bogotá for financial support.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds 10a and 11a are available from the authors.

References

  1. Kihampa, C.; Nkunya, M.H.H.; Joseph, C.C.; Magesa, S.M.; Hassanali, A.; Heydenreich, M.; Kleinpeter, E. Anti-Mosquito and Antimicrobial nor-Halimanoids, Isocoumarins and an Anilinoid from Tessmannia densiflora. Phytochemistry 2009, 70, 1233–1238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Piacente, S.; Pizza, C.; de Tommasi, N.; Vittorio Emanuele, P.; Fisciano, D.; Mahmood, N. Constituents of Ardisia japonica and Their In Vitro Anti-HIV Activity. J. Nat. Prod. 1996, 59, 565–569. [Google Scholar] [CrossRef]
  3. Zeng, W.N.; Cai, J.; Wang, B.; Chen, L.Y.; Pan, C.X.; Chen, S.J.; Huang, G.L.; Zheng, C.J. A New Bioactive Isocoumarin from the Mangrove-Derived Fungus Penicillium sp. TGM112. J. Asian Nat. Prod. Res. 2021, 24, 679–684. [Google Scholar] [CrossRef] [PubMed]
  4. Kim, H.W.; Park, J.; Kang, K.B.; Kim, T.B.; Oh, W.K.; Kim, J.; Sung, S.H. Acylphloroglucinolated Catechin and Phenylethyl Isocoumarin Derivatives from Agrimonia pilosa. J. Nat. Prod. 2016, 79, 2376–2383. [Google Scholar] [CrossRef]
  5. Wijeratne, E.M.K.; Paranagama, P.A.; Gunatilaka, A.A.L. Five New Isocoumarins from Sonoran Desert Plant-associated Fungal Strains Paraphaeosphaeria quadriseptata and Chaetomium chiversii. Tetrahedron 2006, 62, 8439–8446. [Google Scholar] [CrossRef]
  6. Zhang, H.; Matsuda, H.; Kumahara, A.; Ito, Y.; Nakamura, S.; Yoshikawa, M. New Type of Anti-diabetic Compounds from the Processed Leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium). Bioorg. Med. Chem. Lett. 2007, 17, 4972–4976. [Google Scholar] [CrossRef]
  7. Prompanya, C.; Dethoup, T.; Bessa, L.J.; Pinto, M.M.M.; Gales, L.; Costa, P.M.; Silva, A.M.S.; Kijjoa, A. New Isocoumarin Derivatives and Meroterpenoids from the Marine Sponge-Associated Fungus Aspergillus similanensis sp. Nov. KUFA 0013. Mar. Drugs 2014, 12, 5160–5173. [Google Scholar] [CrossRef]
  8. Saeed, A.; Haroon, M.; Muhammad, F.; Larik, F.A.; Hesham, E.-S.; Channar, P.A. Advances in Transition Metal Catalyzed Synthesis of 3-substituted Isocoumarins. J. Organomet. Chem. 2017, 834, 88–103. [Google Scholar] [CrossRef]
  9. Hara, Y.; Onodera, S.; Kochi, T.; Kakiuchi, F. Catalytic Formation of α-Aryl Ketones by C-H Functionalization with Cyclic Alkenyl Carbonates and One-Pot Synthesis of Isocoumarins. Org. Lett. 2015, 17, 4850–4853. [Google Scholar] [CrossRef]
  10. Zheng, M.; Huang, L.; Tong, Q.; Wu, W.; Jiang, H. Oxypalladation Initiating the Oxidative Heck Reaction with Alkenyl Alcohols: Synthesis of Isocoumarin–Alkanones. Eur. J. Org. Chem. 2016, 2016, 663–667. [Google Scholar] [CrossRef]
  11. Teixeira, M.; Alvarenga, E.; Lopes, D.; Oliveira, D. Herbicidal activity of isobenzofuranones and in silico identification of their enzyme target. Pest. Manag. Sci. 2019, 75, 3331–3339. [Google Scholar] [CrossRef] [PubMed]
  12. Arnone, A.; Assante, G.; Nacini, G.; Strada, S.; Vercesi, A. Cryphonectric Acid and Other Minor Metabolites from a Hypovirulent Strain of Cryphonectria parasitica. J. Nat. Prod. 2002, 65, 48–50. [Google Scholar] [CrossRef] [PubMed]
  13. Yılmaz, Z.; Yasin, H.; Şenel, P.; Adımcılar, V.; Erdoğan, T.; Özdemir, A.; Gölcü, A.; Odabaşoğlu, M. A novel 3-((5-methylpyridin-2-yl)amino)isobenzofuran-1(3H)-one: Molecular structure describe X-ray diffractions and DFT calculations, antioxidant activity, DNA binding and molecular docking studies. J. Mol. Struct. 2020, 1205, 127585. [Google Scholar] [CrossRef]
  14. Zou, S.; Wang, Z.; Wang, J.; Wei, G.; Wang, W.; Zang, Y.; Zeng, F.; Chen, K.; Liu, J.; Wang, J.; et al. Azacoccones A-E, five new aza-epicoccone derivatives from Aspergillus flavipes. Fitoterapia 2018, 124, 127–131. [Google Scholar] [CrossRef]
  15. Hou, Y.-T.; Wu, F.; Yao, J.-H.; Zhu, Z.-H.; Mi, Q.-L.; Gao, Q.; Zhou, M.; Ye, Y.-Q.; Wang, W.-G.; Yang, G.-Y.; et al. Chemical constituents of the roots of Phlomis betonicoides and their anti-rotavirus activity. Chem. Nat. Compd. 2021, 57, 864–868. [Google Scholar] [CrossRef]
  16. Chen, L.; Wu, J.; Li, K.; Wu, Q.; Chen, R.; Liu, X.; Ruan, B. Novel phthalide derivatives: Synthesis and anti-inflammatory activity in vitro and in vivo. Eur. J. Med. Chem. 2020, 206, 112722. [Google Scholar] [CrossRef]
  17. Chen, Q.; Yu, J.-J.; He, J.; Feng, T.; Liu, J.-K. Isobenzofuranones and isocoumarins from kiwi endophytic fungus Paraphaeosphaeria sporulosa and their antibacterial activity against Pseudomonas syringae pv. actinidiae. Phytochemistry 2022, 195, 113050. [Google Scholar] [CrossRef] [PubMed]
  18. Li, Y.; Luo, Z.; Luo, B.; Lan, Q.; Fan, J.; Xue, W.; Miao, J.; Li, Y.; Tang, L.; Fan, L. Design, Synthesis and Antifungal Activities of 6-Substituted 3-Butylphthalide Derivatives against Phytopathogenic Fungi. Chem. Biodivers. 2020, 17, e200435. [Google Scholar] [CrossRef]
  19. Sánchez-Fernández, R.; Sánchez-Fuentes, R.; Rangel-Sánchez, H.; Hernández-Ortega, S.; López-Cortés, J.; Macías-Rubalcava, M. Antifungal and antioomycete activities and modes of action of isobenzofuranones isolated from the endophytic fungus Hypoxylon anthochroum strain Gseg1. Pestic. Biochem. Phys. 2020, 169, 104670. [Google Scholar] [CrossRef]
  20. Rodrigues, M.P.; Tomaz, D.C.; de Souza, L.Â.; Onofre, T.S.; de Menezes, W.A.; Almeida, J.; Suarez, A.M.; de Almeida, M.R.; da Silva, A.M.; Costa, G.; et al. Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis. Eur. J. Med. Chem. 2019, 183, 111688. [Google Scholar] [CrossRef]
  21. Karmakar, R.; Pahari, P.; Mal, D. Phthalides and Phthalans: Synthetic Methodologies and Their Applications in the Total Synthesis. Chem. Rev. 2014, 114, 6213–6284. [Google Scholar] [CrossRef] [PubMed]
  22. Kurhade, S.; Rajopadhyay, V.; Avaragolla, S.P.; Koul, S.; Ramaiah, P.A.; Bhuniya, D. Synthesis of L-azaisotryptophan and its analogs: A general access to new 2-substituted azaindoles. Tetrahedron Lett. 2014, 55, 2415–2419. [Google Scholar] [CrossRef]
  23. Nguyen, T.X.; Morrel, A.; Conda-Sheridan, M.; Marchand, C.; Agama, K.; Bermingam, A.; Stephen, A.; Chergui, A.; Naumova, A.; Fisher, R.; et al. Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)–Topoisomerase I (Top1) Inhibitors. J. Med. Chem. 2012, 55, 4457–4478. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Abid, O.H.; Tawfeeq, H.M.; Muslim, R.F. Synthesis and Characterization of Novel 1,3-oxazepin-5(1H)-one Derivatives via Reaction of Imine Compounds with Isobenzofuran-1(3H)-one. Acta Pharm. Sci. 2017, 55, 43–55. [Google Scholar] [CrossRef] [Green Version]
  25. Opatz, T.; Ferenc, D. Facile Preparation of 3-Amino-4-(arylamino)-1H-isochromen-1-ones by a New Multicomponent Reaction. Eur. J. Org. Chem. 2005, 2005, 817–821. [Google Scholar] [CrossRef]
  26. Opatz, T.; Ferenc, D. Ring Contracting Rearrangements of 3-Amino-4-(arylamino)-1H-isochromen-1-ones. Eur. J. Org. Chem. 2006, 2006, 121–126. [Google Scholar] [CrossRef]
Figure 1. Some relevant examples of isobenzofuranones derivatives with demonstrated biological activities.
Figure 1. Some relevant examples of isobenzofuranones derivatives with demonstrated biological activities.
Molbank 2022 m1407 g001
Scheme 1. Summarized pathway of phthalide–imidazolinone spiro-compound target obtention.
Scheme 1. Summarized pathway of phthalide–imidazolinone spiro-compound target obtention.
Molbank 2022 m1407 sch001
Scheme 2. Synthesis of 4-[(3-amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic acid (10a).
Scheme 2. Synthesis of 4-[(3-amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic acid (10a).
Molbank 2022 m1407 sch002
Scheme 3. Synthesis attempts of 1–phenylamino–3–oxo–1,3–dihydroisobenzofuran–1–carboxamide (11b) from 3–amino–4–phenylamino–1H–isochromen–1–one (10b).
Scheme 3. Synthesis attempts of 1–phenylamino–3–oxo–1,3–dihydroisobenzofuran–1–carboxamide (11b) from 3–amino–4–phenylamino–1H–isochromen–1–one (10b).
Molbank 2022 m1407 sch003
Scheme 4. Proposed reaction scheme for the formation of compound 11.
Scheme 4. Proposed reaction scheme for the formation of compound 11.
Molbank 2022 m1407 sch004
Scheme 5. Synthesis of 4-[(1-carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic acid (11a).
Scheme 5. Synthesis of 4-[(1-carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic acid (11a).
Molbank 2022 m1407 sch005
Table 1. Optimization of reaction conditions of 10b to afford 11b; all procedures were performed in DMF.
Table 1. Optimization of reaction conditions of 10b to afford 11b; all procedures were performed in DMF.
EntryConditionsTimeYield (%)
1r.t.1 week52
2HOAc/r.t.48 h57
3HOAc/60 °C48 h43
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Rodríguez, R.; Quiroga-Suavita, F.; Dotor Robayo, M.Y. Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid. Molbank 2022, 2022, M1407. https://doi.org/10.3390/M1407

AMA Style

Rodríguez R, Quiroga-Suavita F, Dotor Robayo MY. Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid. Molbank. 2022; 2022(3):M1407. https://doi.org/10.3390/M1407

Chicago/Turabian Style

Rodríguez, Ricaurte, Felipe Quiroga-Suavita, and Mónica Yadira Dotor Robayo. 2022. "Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid" Molbank 2022, no. 3: M1407. https://doi.org/10.3390/M1407

APA Style

Rodríguez, R., Quiroga-Suavita, F., & Dotor Robayo, M. Y. (2022). Unexpected Formation of 4-[(1-Carbamoyl-3-oxo-1,3-dihydro-2-benzofuran-1-yl)amino]benzoic Acid from 4-[(3-Amino-1-oxo-1H-2-benzopyran-4-yl)amino]benzoic Acid. Molbank, 2022(3), M1407. https://doi.org/10.3390/M1407

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop